The apolipoprotein є4 allele in Parkinson’s disease with and without dementia

Neurology

Volumn 44, Issue 7, 1994, Pages 1330-1331

  Marder, K ^a,b,c   Maestre, G ^b,c   Cote, L ^a,b   Mejia, H ^b   Alfaro, B ^b   Halim, A ^c   Tang, M ^a,b   Tycko, B ^b,c   Mayeux, R ^a,b,c  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b Columbia University School of Public Health ^*  (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; CHEMISTRY; DEMENTIA; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOMERISM; MALE; PARKINSON DISEASE; REFERENCE VALUE; ALZHEIMER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

AGED; ALLELES; APOLIPOPROTEINS E; DEMENTIA; FEMALE; GENOTYPE; HUMAN; ISOMERISM; MALE; PARKINSON DISEASE; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028168115     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.7.1330     Document Type: Article

References (10)

1. Kokmen E, Chandra V, Schoenberg B. Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960-1974. Neurology 1988;38:975–980.
2. Rinne JO, Rummukainen J, Paljarvi L, Rinne UK. Dementia in Parkinson’s disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989;26:47–50.
3. Strittmatter WJ, Saunders A, Schmechel D, et al. Apolipoprotein E: high affinity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977- 1981.
4. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467–1472.
5. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein e4 allele in patients with Alzheimer’s disease. Ann Neurol 1993;34:752–754.
6. Mayeux R, Denaro J, Hemenegildo N, et al. A population- based investigation of Parkinson’s disease with and without dementia; relationship to age and gender. Arch Neurol 1992;49:492–497.
7. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability and factor structure of the Unified Parkinson’s Rating Scale motor examination [abstract]. Ann Neurol 1992;32:250.
8. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhAI. J Lipid Res 1991;31:545–548.
9. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993;261:921–923.
10. Stern Y, Marder K, Tang M-X, Mayeux R. Antecedent clinical features associated with dementia in Parkinson’s disease. Neurology 1993;43:1690–1692.